The global stem cell assay market is expected to grow at a CAGR of 12.5% during the forecast period, from 2021 to 2030. The growth of this market is driven by the increasing demand for stem cells in regenerative medicine and therapy development, drug discovery and development, and clinical research.
The global stem cell assay market is segmented on the basis of type into dermatology stem cell assay, cardiovascular stem cell assay, central nervous system (CNS)stem cell assay, and oncology stem cell assay. The dermatology segment accounted for the largest share in 2018 owing to its wide application in skin care products such as anti-aging creams or lotions that are used for skin rejuvenation purposes. The CNS segment accounted for the second-largest share due to its wide application in neurological disorders such as Alzheimer’s disease or Parkinson’s disease which are characterized by progressive loss of neurons that produce dopamine or acetylcholine respectively.
Oncology was one of the fastest growing segments owing to its wide application in cancer diagnosis and treatment which has led to an increase in cancer incidence rates globally over time. Dermatology was also one of the fastest growing segments due to its wide applications such as wound healing or scar reduction treatments which have increased with an increase in accidents caused by natural disasters like hurricanes or earthquakes across various regions globally over time.
Some Of The Growth Factors Of This Market:
- Increasing research and development activities in the field of regenerative medicine are also expected to fuel the growth of this market over the forecast period.
- Technological advancements in stem cells research are also anticipated to boost this market's growth prospects over the next few years, as they offer promising therapeutic solutions for various diseases such as Alzheimer's disease and Parkinson's disease among others .
Industry Growth Insights published a new data on “Stem Cell Assay Market”. The research report is titled “Stem Cell Assay Market research by Types (Dermatology Stem Cell Assay, Cardiovascular Stem Cell Assay, Central Nervous System Stem Cell Assay, Oncology Stem Cell Assay, Other), By Applications (Regenerative Medicine & Therapy Development, Drug Discovery and Development, Clinical Research, Other), By Players/Companies GE Healthcare, Promega Corporation, Thermo Fisher Scientific, Merck KGaA, Cell Biolabs, Hemogenix, Stemcell Technologies, Bio-Rad Laboratories, Bio-Techne Corporation, Cellular Dynamics International”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Stem Cell Assay Market Research Report
By Type
Dermatology Stem Cell Assay, Cardiovascular Stem Cell Assay, Central Nervous System Stem Cell Assay, Oncology Stem Cell Assay, Other
By Application
Regenerative Medicine & Therapy Development, Drug Discovery and Development, Clinical Research, Other
By Companies
GE Healthcare, Promega Corporation, Thermo Fisher Scientific, Merck KGaA, Cell Biolabs, Hemogenix, Stemcell Technologies, Bio-Rad Laboratories, Bio-Techne Corporation, Cellular Dynamics International
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
237
Number of Tables & Figures
166
Customization Available
Yes, the report can be customized as per your need.
Global Stem Cell Assay Market Report Segments:
The global Stem Cell Assay market is segmented on the basis of:
Types
Dermatology Stem Cell Assay, Cardiovascular Stem Cell Assay, Central Nervous System Stem Cell Assay, Oncology Stem Cell Assay, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Regenerative Medicine & Therapy Development, Drug Discovery and Development, Clinical Research, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- GE Healthcare
- Promega Corporation
- Thermo Fisher Scientific
- Merck KGaA
- Cell Biolabs
- Hemogenix
- Stemcell Technologies
- Bio-Rad Laboratories
- Bio-Techne Corporation
- Cellular Dynamics International
Highlights of The Stem Cell Assay Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Dermatology Stem Cell Assay
- Cardiovascular Stem Cell Assay
- Central Nervous System Stem Cell Assay
- Oncology Stem Cell Assay
- Other
- By Application:
- Regenerative Medicine & Therapy Development
- Drug Discovery and Development
- Clinical Research
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Stem Cell Assay Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A stem cell assay is a laboratory test that uses cells to measure the activity of specific genes or proteins. This information can help scientists understand how a particular treatment or disease affects the cells in a person's body.
Some of the major companies in the stem cell assay market are GE Healthcare, Promega Corporation, Thermo Fisher Scientific, Merck KGaA, Cell Biolabs, Hemogenix, Stemcell Technologies, Bio-Rad Laboratories, Bio-Techne Corporation, Cellular Dynamics International.
The stem cell assay market is expected to register a CAGR of 12.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Stem Cell Assay Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Stem Cell Assay Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Stem Cell Assay Market - Supply Chain
4.5. Global Stem Cell Assay Market Forecast
4.5.1. Stem Cell Assay Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Stem Cell Assay Market Size (000 Units) and Y-o-Y Growth
4.5.3. Stem Cell Assay Market Absolute $ Opportunity
5. Global Stem Cell Assay Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Stem Cell Assay Market Size and Volume Forecast by Type
5.3.1. Dermatology Stem Cell Assay
5.3.2. Cardiovascular Stem Cell Assay
5.3.3. Central Nervous System Stem Cell Assay
5.3.4. Oncology Stem Cell Assay
5.3.5. Other
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Stem Cell Assay Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Stem Cell Assay Market Size and Volume Forecast by Application
6.3.1. Regenerative Medicine & Therapy Development
6.3.2. Drug Discovery and Development
6.3.3. Clinical Research
6.3.4. Other
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Stem Cell Assay Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Stem Cell Assay Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Stem Cell Assay Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Stem Cell Assay Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Stem Cell Assay Demand Share Forecast, 2019-2026
9. North America Stem Cell Assay Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Stem Cell Assay Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Stem Cell Assay Market Size and Volume Forecast by Application
9.4.1. Regenerative Medicine & Therapy Development
9.4.2. Drug Discovery and Development
9.4.3. Clinical Research
9.4.4. Other
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Stem Cell Assay Market Size and Volume Forecast by Type
9.7.1. Dermatology Stem Cell Assay
9.7.2. Cardiovascular Stem Cell Assay
9.7.3. Central Nervous System Stem Cell Assay
9.7.4. Oncology Stem Cell Assay
9.7.5. Other
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Stem Cell Assay Demand Share Forecast, 2019-2026
10. Latin America Stem Cell Assay Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Stem Cell Assay Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Stem Cell Assay Market Size and Volume Forecast by Application
10.4.1. Regenerative Medicine & Therapy Development
10.4.2. Drug Discovery and Development
10.4.3. Clinical Research
10.4.4. Other
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Stem Cell Assay Market Size and Volume Forecast by Type
10.7.1. Dermatology Stem Cell Assay
10.7.2. Cardiovascular Stem Cell Assay
10.7.3. Central Nervous System Stem Cell Assay
10.7.4. Oncology Stem Cell Assay
10.7.5. Other
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Stem Cell Assay Demand Share Forecast, 2019-2026
11. Europe Stem Cell Assay Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Stem Cell Assay Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Stem Cell Assay Market Size and Volume Forecast by Application
11.4.1. Regenerative Medicine & Therapy Development
11.4.2. Drug Discovery and Development
11.4.3. Clinical Research
11.4.4. Other
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Stem Cell Assay Market Size and Volume Forecast by Type
11.7.1. Dermatology Stem Cell Assay
11.7.2. Cardiovascular Stem Cell Assay
11.7.3. Central Nervous System Stem Cell Assay
11.7.4. Oncoloy Stem Cell Assay
11.7.5. Other
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Stem Cell Assay Demand Share, 2019-2026
12. Asia Pacific Stem Cell Assay Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Stem Cell Assay Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Stem Cell Assay Market Size and Volume Forecast by Application
12.4.1. Regenerative Medicine & Therapy Development
12.4.2. Drug Discovery and Development
12.4.3. Clinical Research
12.4.4. Other
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Stem Cell Assay Market Size and Volume Forecast by Type
12.7.1. Dermatology Stem Cell Assay
12.7.2. Cardiovascular Stem Cell Assay
12.7.3. Central Nervous System Stem Cell Assay
12.7.4. Oncology Stem Cell Assay
12.7.5. Other
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Stem Cell Assay Demand Share, 2019-2026
13. Middle East & Africa Stem Cell Assay Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Stem Cell Assay Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Stem Cell Assay Market Size and Volume Forecast by Application
13.4.1. Regenerative Medicine & Therapy Development
13.4.2. Drug Discovery and Development
13.4.3. Clinical Research
13.4.4. Other
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Stem Cell Assay Market Size and Volume Forecast by Type
13.7.1. Dermatology Stem Cell Assay
13.7.2. Cardiovascular Stem Cell Assay
13.7.3. Central Nervous System Stem Cell Assay
13.7.4. Oncology Stem Cell Assay
13.7.5. Other
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Stem Cell Assay Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Stem Cell Assay Market: Market Share Analysis
14.2. Stem Cell Assay Distributors and Customers
14.3. Stem Cell Assay Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. GE Healthcare
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Promega Corporation
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Thermo Fisher Scientific
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Merck KGaA
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Cell Biolabs
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Hemogenix
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Stemcell Technologies
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Bio-Rad Laboratories
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Bio-Techne Corporation
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Cellular Dynamics International
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
